Insmed Incorporated held its annual meeting on May 13, 2026, where shareholders elected two Class II directors and approved executive compensation and auditor ratification.
Key takeaways
Shareholders elected Elizabeth McKee Anderson and Clarissa Desjardins as Class II directors for three-year terms.
Advisory vote on 2025 executive compensation passed with 162,133,728 votes in favor.
Ratification of Ernst & Young as independent auditor for 2026 was approved with 190,386,612 votes for.
Broker non-votes were 11,564,082 for director elections and compensation proposals.
All proposals received majority support from votes cast.